Loading clinical trials...
Loading clinical trials...
An Open-Label Safety Study of Single-dose VGR-R01 in Patients With Bietti Crystalline Dystrophy
Conditions
Interventions
VGR-R01
Locations
1
China
Beijing Tongren Hospital
Beijing, Beijing Municipality, China
Start Date
September 15, 2022
Primary Completion Date
May 1, 2024
Completion Date
May 1, 2024
Last Updated
November 9, 2022
Lead Sponsor
Beijing Tongren Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions